Miami, FL - (November 27, 2006) - Modern Veterinary Therapeutics, LLC announces today that it has received FDA approval for RESPIRAM, a respiratory stimulant for use in dogs, cats and horses. RESPIRAM is indicated to stimulate respirations during and after anesthesia, to speed awakening and return of reflexes after anesthesia and to initiate or stimulate respirations in neonates after dystocia or cesarean section. RESPIRAM will be supplied in 20 mL multidose vials and will be available to veterinarians through distributors.

“The approval of RESPIRAM in record time marks the first milestone for Modern Veterinary Therapeutics, LLC. It is our first product in the $60 Millions anesthetic and critical care therapeutic area. RESPIRAM will be a very important drug to Veterinarians. We are aggressively pursuing worldwide registration of RESPIRAM as well”, said Catherine Berezaie, Managing Director of Modern Veterinary Therapeutics, LLC.